Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lianhe Aigen Pharma is a full-service pharmaceutical contract development and manufacturing organization (CDMO) with an emphasis on integrated chemical solutions from drug discovery through commercial production. The company's facilities have been successfully inspected by the FDA, EMA, PMDA, TGA, KFDA, and NMPA, and it operates under GMP and ISO 9001 standards. Its offerings include library synthesis, hit and lead optimization, process development, analytical services, and regulatory support, as well as commercial-scale manufacture of active pharmaceutical ingredients (APIs) and advanced intermediates for global pharmaceutical customers[1][2][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lianhe World.